146 related articles for article (PubMed ID: 23381931)
21. Distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium.
Hua R; Adamczyk A; Robbins C; Ray G; Rose RA
PLoS One; 2012; 7(10):e47652. PubMed ID: 23077656
[TBL] [Abstract][Full Text] [Related]
22. Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.
Adderley SP; Dufaux EA; Sridharan M; Bowles EA; Hanson MS; Stephenson AH; Ellsworth ML; Sprague RS
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1617-24. PubMed ID: 19252089
[TBL] [Abstract][Full Text] [Related]
23. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
[TBL] [Abstract][Full Text] [Related]
24. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells.
Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kaupisch A; Kane NM; Baillie GS; Baker AH; Milligan G; Houslay MD; Mountford JC
Biochem J; 2010 Dec; 432(3):575-84. PubMed ID: 20923411
[TBL] [Abstract][Full Text] [Related]
25. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes.
Weiss HR; Lazar MJ; Punjabi K; Tse J; Scholz PM
Eur J Pharmacol; 2003 Nov; 481(1):25-31. PubMed ID: 14637171
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
Duncan GS; Wolberg G; Schmitges CJ; Deeprose RD; Zimmerman TP
J Immunopharmacol; 1982; 4(1-2):79-100. PubMed ID: 6296234
[TBL] [Abstract][Full Text] [Related]
27. Expression and role of phosphodiesterase 5 in human malignant melanoma cell line.
Murata T; Shimizu K; Watanabe Y; Morita H; Sekida M; Tagawa T
Anticancer Res; 2010 Feb; 30(2):355-8. PubMed ID: 20332439
[TBL] [Abstract][Full Text] [Related]
28. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
Vandecasteele G; Verde I; Rücker-Martin C; Donzeau-Gouge P; Fischmeister R
J Physiol; 2001 Jun; 533(Pt 2):329-40. PubMed ID: 11389195
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
31. Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction.
Geoffroy V; Fouque F; Nivet V; Clot JP; Lugnier C; Desbuquois B; Benelli C
Eur J Biochem; 1999 Feb; 259(3):892-900. PubMed ID: 10092879
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study.
Kedia GT; Oelke M; Sonnenberg JE; Sohn M; Bannowsky A; Kuczyk MA; Ückert S
Eur J Pharmacol; 2014 Oct; 741():330-5. PubMed ID: 25160741
[TBL] [Abstract][Full Text] [Related]
33. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
34. Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking.
Song RS; Tolentino R; Sobie EA; Neves-Zaph SR
J Biol Chem; 2016 Oct; 291(44):23257-23267. PubMed ID: 27605670
[TBL] [Abstract][Full Text] [Related]
35. Characterization of renal ecto-phosphodiesterase.
Jackson EK; Ren J; Zacharia LC; Mi Z
J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
[TBL] [Abstract][Full Text] [Related]
36. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
Hepp R; Tricoire L; Hu E; Gervasi N; Paupardin-Tritsch D; Lambolez B; Vincent P
J Neurochem; 2007 Sep; 102(6):1875-1886. PubMed ID: 17561940
[TBL] [Abstract][Full Text] [Related]
38. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine.
Podzuweit T; Nennstiel P; Müller A
Cell Signal; 1995 Sep; 7(7):733-8. PubMed ID: 8519602
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase.
Rosman GJ; Martins TJ; Sonnenburg WK; Beavo JA; Ferguson K; Loughney K
Gene; 1997 May; 191(1):89-95. PubMed ID: 9210593
[TBL] [Abstract][Full Text] [Related]
40. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat.
van Staveren WC ; Markerink-van Ittersum M ; Steinbusch HW; de Vente J
Brain Res; 2001 Jan; 888(2):275-286. PubMed ID: 11150485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]